Regulation of Orai1/STIM1 by the kinases SGK1 and AMPK

Cell Calcium

Volumn 52, Issue 5, 2012, Pages 347-354

  Lang, Florian ^a   Eylenstein, Anja ^a   Shumilina, Ekaterina ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cell death; Dendritic cells; Migration; NF B

Indexed keywords

CALCIUM ION; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CASPASE 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; STROMAL INTERACTION MOLECULE 1; UBIQUITIN PROTEIN LIGASE NEDD4;

CALCIUM SIGNALING; CALCIUM TRANSPORT; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE; GENE EXPRESSION REGULATION; NONHUMAN; ORAI1 GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; STROMAL INTERACTION MOLECULE 1 GENE; UBIQUITINATION;

EID: 84866753209     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2012.05.005     Document Type: Review

References (177)

1. 2+ signalling. Nature Reviews. Neuroscience 2007, 8:182-193.
2. Orrenius S., Zhivotovsky B., Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nature Reviews. Molecular Cell Biology 2003, 4:552-565.
3. 2+ for cancer cell proliferation and survival. Nature Reviews. Cancer 2008, 8:361-375.
4. Salter R.D., Watkins S.C. Dendritic cell altered states: what role for calcium?. Immunological Reviews 2009, 231:278-288.
5. Becchetti A., Arcangeli A. Integrins and ion channels in cell migration: implications for neuronal development, wound healing and metastatic spread. Advances in Experimental Medicine and Biology 2010, 674:107-123.
6. Parekh A.B., Penner R. Store depletion and calcium influx. Physiological Reviews 1997, 77:901-930.
7. Putney J.W. Capacitative calcium entry: sensing the calcium stores. Journal of Cell Biology 2005, 169:381-382.
8. Cahalan M.D., Zhang S.L., Yeromin A.V., Ohlsen K., Roos J., Stauderman K.A. Molecular basis of the CRAC channel. Cell Calcium 2007, 42:133-144.
9. Prakriya M., Feske S., Gwack Y., Srikanth S., Rao A., Hogan P.G. Orai1 is an essential pore subunit of the CRAC channel. Nature 2006, 443:230-233.
10. 2+ entry. Science 2006, 312:1220-1223.
11. 2+ channel activity of human Orai1 and Orai3. Journal of Biological Chemistry 2008, 283:17662-17671.
12. Hogan P.G., Lewis R.S., Rao A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annual Review of Immunology 2010, 28:491-533.
13. Fahrner M., Muik M., Derler I., et al. Mechanistic view on domains mediating STIM1-Orai coupling. Immunological Reviews 2009, 231:99-112.
14. Peinelt C., Vig M., Koomoa D.L., et al. Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nature Cell Biology 2006, 8:771-773.
15. Penna A., Demuro A., Yeromin A.V., et al. The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers. Nature 2008, 456:116-120.
16. Feske S. Calcium signalling in lymphocyte activation and disease. Nature Reviews. Immunology 2007, 7:690-702.
17. Schaff U.Y., Dixit N., Procyk E., Yamayoshi I., Tse T., Simon S.I. Orai1 regulates intracellular calcium, arrest, and shape polarization during neutrophil recruitment in shear flow. Blood 2010, 115:657-666.
18. Shin D.M., Muallem S. Skeletal muscle dressed in SOCs. Nature Cell Biology 2008, 10:639-641.
19. 2+ channel Orai1 and its internalization during meiosis. Journal of Cell Biology 2010, 191:523-535.
20. 2+ pump in proliferating human arterial myocytes. American Journal of Physiology Cell Physiology 2009, 297:C1103-C1112.
21. Faouzi M., Hague F., Potier M., Ahidouch A., Sevestre H., Ouadid-Ahidouch H. Down-regulation of Orai3 arrests cell cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. Journal of Cellular Physiology 2011, 226:542-551.
22. Motiani R.K., Abdullaev I.F., Trebak M. A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. Journal of Biological Chemistry 2010, 285:19173-19183.
23. Johnstone L.S., Graham S.J., Dziadek M.A. STIM proteins: integrators of signalling pathways in development, differentiation and disease. Journal of Cellular and Molecular Medicine 2010, 14:1890-1903.
24. Yang S., Zhang J.J., Huang X.Y. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 2009, 15:124-134.
25. 2+ concentration. Cellular Signalling 2009, 21:1698-1705.
26. 2+ entry in dystrophic mdx mouse muscle. American Journal of Physiology. Cell Physiology 2010, 299:C42-C50.
27. Picard C., McCarl C.A., Papolos A., et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. New England Journal of Medicine 2009, 360:1971-1980.
28. 2+ entry (SOCE) in islet cells. Journal of Biological Chemistry 2012, 287:9862-9872.
29. Jardin I., Albarran L., Bermejo N., Salido G.M., Rosado J.A. Homers regulate calcium entry and aggregation in human platelets. A role for Homers in the association between STIM1 and Orai1. Biochemical Journal 2012, (Epub ahead of print; April 17).
30. Lopez E., Jardin I., Berna-Erro A., et al. STIM1 tyrosine-phosphorylation is required for STIM1-Orai1 association in human platelets. Cellular Signalling 2012, 24:1315-1322.
31. 2+/calmodulin-, Src- and PP2A-mediated pathway and promote melanoma tumor growth. Carcinogenesis 2012, 33:740-750.
32. Bakowski D., Nelson C., Parekh A.B. Endoplasmic reticulum-mitochondria coupling: local Ca(2+) signalling with functional consequences. Pflugers Archiv 2012, (Epub ahead of print; March 14).
33. Oakes S.A. Mitochondria control calcium entry at the immunological synapse. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:15171-15172.
34. Ercan E., Chung S.H., Bhardwaj R., Seedorf M. Di-arginine signals and the K-rich domain retain the Ca(2+) sensor STIM1 in the endoplasmic reticulum. Traffic 2012, (Epub ahead of print; April 12). 10.1111/j.1600-0854.2012.01359.x.
35. Smyth J.T., Putney J.W. Regulation of store-operated calcium entry during cell division. Biochemical Society Transactions 2012, 40:119-123.
36. 2+-channel Orai1/STIM1 by serum- and glucocorticoid-inducible kinase 1 (SGK1). FASEB Journal 2011, 25:2012-2021.
37. Almaca J., Kongsuphol P., Hieke B., et al. AMPK controls epithelial Na(+) channels through Nedd4-2 and causes an epithelial phenotype when mutated. Pflugers Archiv 2009, 458:713-721.
38. + channel through functional regulation of the ubiquitin ligase Nedd4-2. Journal of Biological Chemistry 2006, 281:26159-26169.
39. Carattino M.D., Edinger R.S., Grieser H.J., et al. Epithelial sodium channel inhibition by AMP-activated protein kinase in oocytes and polarized renal epithelial cells. Journal of Biological Chemistry 2005, 280:17608-17616.
40. Lang F., Bohmer C., Palmada M., Seebohm G., Strutz-Seebohm N., Vallon V. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiological Reviews 2006, 86:1151-1178.
41. Snyder P.M. Down-regulating destruction: phosphorylation regulates the E3 ubiquitin ligase Nedd4-2. Science Signaling 2009, 2:e41.
42. - cotransporter via the aldosterone-SGK1-Nedd4-2 pathway. Journal of the American Society of Nephrology 2011, 22:1707-1719.
43. Bhargava A., Pearce D. Mechanisms of mineralocorticoid action: determinants of receptor specificity and actions of regulated gene products. Trends in Endocrinology and Metabolism 2004, 15:147-153.
44. Boehmer C., Laufer J., Jeyaraj S., et al. Modulation of the voltage-gated potassium channel Kv1.5 by the SGK1 protein kinase involves inhibition of channel ubiquitination. Cellular Physiology and Biochemistry 2008, 22:591-600.
45. Caohuy H., Jozwik C., Pollard H.B. Rescue of DeltaF508-CFTR by the SGK1/Nedd4-2 signaling pathway. Journal of Biological Chemistry 2009, 284:25241-25253.
46. Chandran S., Li H., Dong W., et al. Neural precursor cell-expressed developmentally down-regulated protein 4-2 (Nedd4-2) regulation by 14-3-3 protein binding at canonical serum and glucocorticoid kinase 1 (SGK1) phosphorylation sites. Journal of Biological Chemistry 2011, 286:37830-37840.
47. Flores S.Y., Debonneville C., Staub O. The role of Nedd4/Nedd4-like dependant ubiquitylation in epithelial transport processes. Pflugers Archiv 2003, 446:334-338.
48. Lang F., Artunc F., Vallon V. The physiological impact of the serum and glucocorticoid-inducible kinase SGK1. Current Opinion in Nephrology and Hypertension 2009, 18:439-448.
49. + channels by aldosterone: role of Sgk1. Clinical and Experimental Pharmacology and Physiology 2008, 35:235-241.
50. Soundararajan R., Melters D., Shih I.C., Wang J., Pearce D. Epithelial sodium channel regulated by differential composition of a signaling complex. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:7804-7809.
51. Verrey F., Fakitsas P., Adam G., Staub O. Early transcriptional control of ENaC (de)ubiquitylation by aldosterone. Kidney International 2008, 73:691-696.
52. Wiemuth D., Lott J.S., Ly K., et al. Interaction of serum- and glucocorticoid regulated kinase 1 (SGK1) with the WW-domains of Nedd4-2 is required for epithelial sodium channel regulation. PLoS One 2010, 5:e12163.
53. Keil J.M., Shen Z., Briggs S.P., Patrick G.N. Regulation of STIM1 and SOCE by the ubiquitin-proteasome system (UPS). PLoS One 2010, 5:e13465.
54. Borst O., Schmidt E.M., Munzer P., et al. The serum- and glucocorticoid-inducible kinase 1 (SGK1) influences platelet calcium signaling and function by regulation of Orai1 expression in megakaryocytes. Blood 2012, 119:251-261.
55. 2+ entry and affect cellular functions. Journal of Biological Chemistry 2012, 287:2719-2730.
56. Dolmetsch R.E., Xu K., Lewis R.S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998, 392:933-936.
57. Shih V.F., Tsui R., Caldwell A., Hoffmann A. A single NFkappaB system for both canonical and non-canonical signaling. Cell Research 2011, 21:86-102.
58. Belaiba R.S., Djordjevic T., Bonello S., et al. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. Circulation Research 2006, 98:828-836.
59. Vallon V., Wyatt A.W., Klingel K., et al. SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. Journal of Molecular Medicine 2006, 84:396-404.
60. Criollo A., Senovilla L., Authier H., et al. IKK connects autophagy to major stress pathways. Autophagy 2010, 6:189-191.
61. Lu S.C. Regulation of glutathione synthesis. Molecular Aspects of Medicine 2009, 30:42-59.
62. Monici M.C., Aguennouz M., Mazzeo A., Messina C., Vita G. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 2003, 60:993-997.
63. Porter J.D., Merriam A.P., Leahy P., Gong B., Khanna S. Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Human Molecular Genetics 2003, 12:1813-1821.
64. Mandrup-Poulsen T., Pickersgill L., Donath M.Y. Blockade of interleukin 1 in type 1 diabetes mellitus. Nature Reviews. Endocrinology 2010, 6:158-166.
65. Kasinski A.L., Slack F.J. Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling. Current Opinion in Molecular Therapeutics 2010, 12:147-157.
66. Shen H.M., Tergaonkar V. NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis 2009, 14:348-363.
67. Tisdale M.J. Mechanisms of cancer cachexia. Physiological Reviews 2009, 89:381-410.
68. Ruan H., Pownall H.J. The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance. Current Opinion in Investigational Drugs 2009, 10:346-352.
69. Jandeleit-Dahm K., Cooper M.E. The role of AGEs in cardiovascular disease. Current Pharmaceutical Design 2008, 14:979-986.
70. O'Brien C.A. Control of RANKL gene expression. Bone 2010, 46:911-919.
71. Reid I.R. Anti-resorptive therapies for osteoporosis. Seminars in Cell and Developmental Biology 2008, 19:473-478.
72. Leong M.L., Maiyar A.C., Kim B., O'Keeffe B.A., Firestone G.L. Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. Journal of Biological Chemistry 2003, 278:5871-5882.
73. Rudd C.E., Taylor A., Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunological Reviews 2009, 229:12-26.
74. Segal R.A. Selectivity in neurotrophin signaling: theme and variations. Annual Review of Neuroscience 2003, 26:299-330.
75. Wang K., Gu S., Nasir O., et al. SGK1-dependent intestinal tumor growth in APC-deficient mice. Cellular Physiology and Biochemistry 2010, 25:271-278.
76. Lang F., Perrotti N., Stournaras C. Colorectal carcinoma cells-regulation of survival and growth by SGK1. International Journal of Biochemistry and Cell Biology 2010, 42:1571-1575.
77. Alesutan I.S., Ureche O.N., Laufer J., et al. Regulation of the glutamate transporter EAAT4 by PIKfyve. Cellular Physiology and Biochemistry 2010, 25:187-194.
78. Bohmer C., Sopjani M., Klaus F., et al. The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19. Cellular Physiology and Biochemistry 2010, 25:723-732.
79. Jin H.S., Hong K.W., Lim J.E., et al. Genetic variations in the sodium balance-regulating genes ENaC, NEDD4L, NDFIP2 and USP2 influence blood pressure and hypertension. Kidney and Blood Pressure Research 2010, 33:15-23.
80. Menniti M., Iuliano R., Foller M., et al. 60kDa lysophospholipase, a new Sgk1 molecular partner involved in the regulation of ENaC. Cellular Physiology and Biochemistry 2010, 26:587-596.
81. + channel (ENaC) at multiple levels. American Journal of Physiology. Renal Physiology 2010, 299:F63-F76.
82. Rexhepaj R., Rotte A., Pasham V., Gu S., Kempe D.S., Lang F. PI3 kinase and PDK1 in the regulation of the electrogenic intestinal dipeptide transport. Cellular Physiology and Biochemistry 2010, 25:715-722.
83. + exchanger activity in dendritic cells. Cellular Physiology and Biochemistry 2011, 28:305-314.
84. Liang X., Butterworth M.B., Peters K.W., Walker W.H., Frizzell R.A. An obligatory heterodimer of 14-3-3beta and 14-3-3epsilon is required for aldosterone regulation of the epithelial sodium channel. Journal of Biological Chemistry 2008, 283:27418-27425.
85. Tai D.J., Su C.C., Ma Y.L., Lee E.H. SGK1 phosphorylation of IkappaB kinase alpha and p300 up-regulates NF-kappaB activity and increases N-methyl-d-aspartate receptor NR2A and NR2B expression. Journal of Biological Chemistry 2009, 284:4073-4089.
86. Zhang L., Cui R., Cheng X., Du J. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I{kappa}B kinase. Cancer Research 2005, 65:457-464.
87. Ali K., Bilancio A., Thomas M., et al. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 2004, 431:1007-1011.
88. Murray J.T., Campbell D.G., Morrice N., et al. Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. Biochemical Journal 2004, 384:477-488.
89. Bandyopadhyay S., Pai S.K., Gross S.C., et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Research 2003, 63:1731-1736.
90. Fotovati A., Fujii T., Yamaguchi M., et al. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells. Clinical Cancer Research 2006, 12:3010-3018.
91. Maruyama Y., Ono M., Kawahara A., et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Research 2006, 66:6233-6242.
92. Hosoi F., Izumi H., Kawahara A., et al. N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression. Cancer Research 2009, 69:4983-4991.
93. Murakami Y., Hosoi F., Izumi H., et al. Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells. Biochemical and Biophysical Research Communications 2010, 396:376-381.
94. Kachhap S.K., Faith D., Qian D.Z., et al. The N-Myc down regulated Gene1 (NDRG1) is a Rab4a effector involved in vesicular recycling of E-cadherin. PLoS One 2007, 2:e844.
95. Song Y., Oda Y., Hori M., et al. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Human Pathology 2010, 41:214-222.
96. Sobiesiak M., Shumilina E., Lam R.S., et al. Impaired mast cell activation in gene targeted mice lacking the serum- and glucocorticoid-inducible kinase SGK1. Journal of Immunology 2009, 183:4395-4402.
97. Baba Y., Nishida K., Fujii Y., Hirano T., Hikida M., Kurosaki T. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nature Immunology 2008, 9:81-88.
98. Vig M., DeHaven W.I., Bird G.S., et al. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nature Immunology 2008, 9:89-96.
99. 2+ entry via TRPC channels is necessary for thrombin-induced NF-kappaB activation in endothelial cells through AMP-activated protein kinase and protein kinase Cdelta. Journal of Biological Chemistry 2009, 284:563-574.
100. Mungai P.T., Waypa G.B., Jairaman A., et al. Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels. Molecular and Cellular Biology 2011, 31:3531-3545.
101. Towler M.C., Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circulation Research 2007, 100:328-341.
102. 2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner. American Journal of Physiology Cell Physiology 2009, 296:C346-C354.
103. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. Journal of Biological Chemistry 2005, 280:29060-29066.
104. Woods A., Johnstone S.R., Dickerson K., et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Current Biology 2003, 13:2004-2008.
105. Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiological Reviews 2009, 89:1025-1078.
106. Winder W.W., Thomson D.M. Cellular energy sensing and signaling by AMP-activated protein kinase. Cell Biochemistry and Biophysics 2007, 47:332-347.
107. Hardie D.G. AMPK: a key regulator of energy balance in the single cell and the whole organism. International Journal of Obesity 2008, 32(Suppl. 4):S7-S12.
108. Kim Y.K., Park J.H., Park S.H., et al. Protective role of glucagon-like peptide-1 against glucosamine-induced cytotoxicity in pancreatic beta cells. Cellular Physiology and Biochemistry 2010, 25:211-220.
109. McGee S.L., Hargreaves M. AMPK and transcriptional regulation. Frontiers in Bioscience 2008, 13:3022-3033.
110. Breen D.M., Sanli T., Giacca A., Tsiani E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochemical and Biophysical Research Communications 2008, 374:117-122.
111. Carling D. The role of the AMP-activated protein kinase in the regulation of energy homeostasis. Novartis Foundation Symposium 2007, 286:72-81.
112. Guan F., Yu B., Qi G.X., Hu J., Zeng D.Y., Luo J. Chemical hypoxia-induced glucose transporter-4 translocation in neonatal rat cardiomyocytes. Archives of Medical Research 2008, 39:52-60.
113. Horie T., Ono K., Nagao K., et al. Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes. Journal of Cellular Physiology 2008, 215:733-742.
114. Jensen T.E., Rose A.J., Hellsten Y., Wojtaszewski J.F., Richter E.A. Caffeine-induced Ca(2+) release increases AMPK-dependent glucose uptake in rodent soleus muscle. American Journal of Physiology. Endocrinology and Metabolism 2007, 293:E286-E292.
115. Kim T., Davis J., Zhang A.J., He X., Mathews S.T. Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochemical and Biophysical Research Communications 2009, 388:377-382.
116. Kohan A.B., Talukdar I., Walsh C.M., Salati L.M. A role for AMPK in the inhibition of glucose-6-phosphate dehydrogenase by polyunsaturated fatty acids. Biochemical and Biophysical Research Communications 2009, 388:117-121.
117. Lage R., Vazquez M.J., Varela L., et al. Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB Journal 2010, 24:2670-2679.
118. Lei B., Matsuo K., Labinskyy V., et al. Exogenous nitric oxide reduces glucose transporters translocation and lactate production in ischemic myocardium in vivo. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:6966-6971.
119. Li J., Hu X., Selvakumar P., et al. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. American Journal of Physiology. Endocrinology and Metabolism 2004, 287:E834-E841.
120. Liu Q., Gauthier M.S., Sun L., Ruderman N., Lodish H. Activation of AMP-activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl-CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP/ATP ratio. FASEB Journal 2010, 24:4229-4239.
121. Luiken J.J., Coort S.L., Koonen D.P., et al. Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters. Pflugers Archiv 2004, 448:1-15.
122. MacLean P.S., Zheng D., Jones J.P., Olson A.L., Dohm G.L. Exercise-induced transcription of the muscle glucose transporter (GLUT 4) gene. Biochemical and Biophysical Research Communications 2002, 292:409-414.
123. Natsuizaka M., Ozasa M., Darmanin S., et al. Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia. Experimental Cell Research 2007, 313:3337-3348.
124. Ojuka E.O., Nolte L.A., Holloszy J.O. Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro. Journal of Applied Physiology 2000, 88:1072-1075.
125. Osawa Y., Seki E., Kodama Y., et al. Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression. FASEB Journal 2011, 25:1133-1144.
126. Ota S., Horigome K., Ishii T., et al. Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism. Biochemical and Biophysical Research Communications 2009, 388:311-316.
127. Park S., Scheffler T.L., Gunawan A.M., et al. Chronic elevated calcium blocks AMPK-induced GLUT-4 expression in skeletal muscle. American Journal of Physiology. Cell Physiology 2009, 296:C106-C115.
128. Song H., Guan Y., Zhang L., Li K., Dong C. SPARC interacts with AMPK and regulates GLUT4 expression. Biochemical and Biophysical Research Communications 2010, 396:961-966.
129. +-coupled glucose carrier SGLT1 by AMP-activated protein kinase. Molecular Membrane Biology 2010, 27:137-144.
130. Walker J., Jijon H.B., Diaz H., Salehi P., Churchill T., Madsen L.K. 5-Aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK. Biochemical Journal 2005, 385:485-491.
131. Winder W.W., Holmes B.F., Rubink D.S., Jensen E.B., Chen M., Holloszy J.O. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. Journal of Applied Physiology 2000, 88:2219-2226.
132. Zheng D., MacLean P.S., Pohnert S.C., et al. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. Journal of Applied Physiology 2001, 91:1073-1083.
133. Zygmunt K., Faubert B., MacNeil J., Tsiani E. Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochemical and Biophysical Research Communications 2010, 398:178-183.
134. Lantier L., Mounier R., Leclerc J., Pende M., Foretz M., Viollet B. Coordinated maintenance of muscle cell size control by AMP-activated protein kinase. FASEB Journal 2010, 24:3555-3561.
135. Mounier R., Lantier L., Leclerc J., et al. Important role for AMPKalpha1 in limiting skeletal muscle cell hypertrophy. FASEB Journal 2009, 23:2264-2273.
136. Summermatter S., Mainieri D., Russell A.P., et al. Thrifty metabolism that favors fat storage after caloric restriction: a role for skeletal muscle phosphatidylinositol-3-kinase activity and AMP-activated protein kinase. FASEB Journal 2008, 22:774-785.
137. Caretti A., Bianciardi P., Sala G., Terruzzi C., Lucchina F., Samaja M. Supplementation of creatine and ribose prevents apoptosis in ischemic cardiomyocytes. Cellular Physiology and Biochemistry 2010, 26:831-838.
138. Foller M., Sopjani M., Koka S., et al. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB Journal 2009, 23:1072-1080.
139. Lang F., Gulbins E., Lang P.A., Zappulla D., Foller M. Ceramide in suicidal death of erythrocytes. Cellular Physiology and Biochemistry 2010, 26:21-28.
140. Yang D., Yaguchi T., Nakano T., Nishizaki T. Adenosine activates AMPK to phosphorylate Bcl-XL responsible for mitochondrial damage and DIABLO release in HuH-7 cells. Cellular Physiology and Biochemistry 2011, 27:71-78.
141. Theodoropoulou S., Kolovou P.E., Morizane Y., et al. Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase. FASEB Journal 2010, 24:2620-2630.
142. Zhuo L., Fu B., Bai X., et al. NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway. Cellular Physiology and Biochemistry 2011, 27:681-690.
143. Bae H.B., Zmijewski J.W., Deshane J.S., et al. AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils. FASEB Journal 2011, 25:4358-4368.
144. Vingtdeux V., Chandakkar P., Zhao H., d'Abramo C., Davies P., Marambaud P. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation. FASEB Journal 2011, 25:219-231.
145. +-coupled glutamate transporter EAAT3 and EAAT4 by AMP-activated protein kinase. Journal of Neurochemistry 2010, 113:1426-1435.
146. + exchanger by the AMP-activated protein kinase. Biochemical and Biophysical Research Communications 2010, 398:677-682.
147. Gusarova G.A., Trejo H.E., Dada L.A., et al. Hypoxia leads to Na,K-ATPase downregulation via Ca(2+) release-activated Ca(2+) channels and AMPK activation. Molecular and Cellular Biology 2011, 31:3546-3556.
148. +-permeable channels in H441 human lung epithelial cell monolayers. American Journal of Physiology. Lung Cellular and Molecular Physiology 2008, 295:L837-L848.
149. Alesutan I., Munoz C., Sopjani M., et al. Inhibition of Kir2.1 (KCNJ2) by the AMP-activated protein kinase. Biochemical and Biophysical Research Communications 2011, 408:505-510.
150. Alesutan I., Sopjani M., Munoz C., et al. Inhibition of connexin 26 by the AMP-activated protein kinase. Journal of Membrane Biology 2011, 240:151-158.
151. + channel KCNQ1/KCNE1 by the AMP-activated protein kinase. Molecular Membrane Biology 2011, 28:79-89.
152. Alzamora R., Gong F., Rondanino C., et al. AMP-activated protein kinase inhibits KCNQ1 channels through regulation of the ubiquitin ligase Nedd4-2 in renal epithelial cells. American Journal of Physiology. Renal Physiology 2010, 299:F1308-F1319.
153. Andersen M.N., Krzystanek K., Jespersen T., Olesen S.P., Rasmussen H.B. AMP-activated protein kinase downregulates Kv7.1 cell surface expression. Traffic 2012, 13:143-156.
154. Dallas M.L., Scragg J.L., Wyatt C.N., et al. Modulation of O(2) sensitive K(+) channels by AMP-activated protein kinase. Advances in Experimental Medicine and Biology 2009, 648:57-63.
155. Dallas M.L., Scragg J.L., Peers C. Inhibition of L-type Ca(2+) channels by carbon monoxide. Advances in Experimental Medicine and Biology 2009, 648:89-95.
156. Evans A.M., Hardie D.G., Peers C., et al. Ion channel regulation by AMPK: the route of hypoxia-response coupling in the carotid body and pulmonary artery. Annals of the New York Academy of Sciences 2009, 1177:89-100.
157. Hirschler-Laszkiewicz I., Tong Q., Waybill K., et al. The transient receptor potential (TRP) channel TRPC3 TRP domain and AMP-activated protein kinase binding site are required for TRPC3 activation by erythropoietin. Journal of Biological Chemistry 2011, 286:30636-30646.
158. Kreneisz O., Benoit J.P., Bayliss D.A., Mulkey D.K. AMP-activated protein kinase inhibits TREK channels. Journal of Physiology 2009, 587:5819-5830.
159. + transport in H441 lung epithelial cells. Journal of Physiology 2008, 586:4541-4557.
160. Myerburg M.M., King J.D., Oyster N.M., et al. AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells. American Journal of Respiratory Cell and Molecular Biology 2010, 42:676-684.
161. Ross F.A., Rafferty J.N., Dallas M.L., et al. Selective expression in carotid body type I cells of a single splice variant of the large conductance calcium- and voltage-activated potassium channel confers regulation by AMP-activated protein kinase. Journal of Biological Chemistry 2011, 286:11929-11936.
162. Sidani S., Kopic S., Socrates T., et al. AMP-activated protein kinase: a physiological off switch for murine gastric acid secretion. Pflugers Archiv 2009, 459:39-46.
163. 2+ entry in human pulmonary artery smooth muscle cells in response to hypoxia. Physiological Research 2010, 59:909-918.
164. Turrell H.E., Rodrigo G.C., Norman R.I., Dickens M., Standen N.B. Phenylephrine preconditioning involves modulation of cardiac sarcolemmal K(ATP) current by PKC delta, AMPK and p38 MAPK. Journal of Molecular and Cellular Cardiology 2011, 51:370-380.
165. Yoshida H., Bao L., Kefaloyianni E., et al. AMP-activated protein kinase connects cellular energy metabolism to KATP channel function. Journal of Molecular and Cellular Cardiology 2012, 52:410-418.
166. Kopic S., Corradini S., Sidani S., et al. Ethanol inhibits gastric acid secretion in rats through increased AMP-kinase activity. Cellular Physiology and Biochemistry 2010, 25:195-202.
167. Bess E., Fisslthaler B., Fromel T., Fleming I. Nitric oxide-induced activation of the AMP-activated protein kinase alpha2 subunit attenuates IkappaB kinase activity and inflammatory responses in endothelial cells. PLoS One 2011, 6:e20848.
168. Han Q., Zhang X., Xue R., et al. AMPK potentiates hypertonicity-induced apoptosis by suppressing NFkappaB/COX-2 in medullary interstitial cells. Journal of the American Society of Nephrology 2011, 22:1897-1911.
169. 2+ exchanger activity in dendritic cells from AMP-activated protein kinase deficient mice. FASEB Journal 2012, (Epub ahead of print; April 2).
170. Bandyopadhyay B.C., Pingle S.C., Ahern G.P. Store-operated Ca(2)+ signaling in dendritic cells occurs independently of STIM1. Journal of Leukocyte Biology 2011, 89:57-62.
171. 2+ signaling in the regulation of dendritic cell functions. American Journal of Physiology. Cell Physiology 2011, 300:C1205-C1214.
172. Sag D., Carling D., Stout R.D., Suttles J. Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. Journal of Immunology 2008, 181:8633-8641.
173. Barbet G., Demion M., Moura I.C., et al. The calcium-activated nonselective cation channel TRPM4 is essential for the migration but not the maturation of dendritic cells. Nature Immunology 2008, 9:1148-1156.
174. Koski G.K., Schwartz G.N., Weng D.E., et al. Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. Journal of Immunology 1999, 163:82-92.
175. Partida-Sanchez S., Gasser A., Fliegert R., et al. Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by adp-ribose, the major product generated by the CD38 enzyme reaction. Journal of Immunology 2007, 179:7827-7839.
176. Rubartelli A., Poggi A., Zocchi M.R. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. European Journal of Immunology 1997, 27:1893-1900.
177. Krawczyk C.M., Holowka T., Sun J., et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 2010, 115:4742-4749.